摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-(3-hydroxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one

中文名称
——
中文别名
——
英文名称
(E)-1-(3-hydroxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one
英文别名
3-(4-chloro-phenyl)-1-(3-hydroxy-phenyl)-propenone;(E)-3-(4-chlorophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one
(E)-1-(3-hydroxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one化学式
CAS
——
化学式
C15H11ClO2
mdl
——
分子量
258.704
InChiKey
CJOVLNZNTALCJV-RMKNXTFCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (E)-1-(3-hydroxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one(E)-1-(3-hydroxyphenyl)-3-phenylprop-2-en-1-one 反应 96.0h, 以to obtain the title compound (48%)的产率得到3-(4-chlorophenyl)-2,3-dihydro-6-hydroxyinden-1-one
    参考文献:
    名称:
    Indenone derivative and pharmaceutical composition comprising same
    摘要:
    公式(1)的吲哚酮衍生物能够有效提高成骨细胞的活性,抑制破骨细胞的骨吸收,并且含有该吲哚酮衍生物或其药学上可接受的盐的制药组合物可用于预防或治疗骨质疏松等骨疾病。
    公开号:
    US08877747B2
  • 作为产物:
    描述:
    3-羟基苯乙酮4-氯苯甲醛 在 sodium hydroxide 作用下, 以 乙醇 为溶剂, 以78%的产率得到(E)-1-(3-hydroxyphenyl)-3-(4-chlorophenyl)prop-2-en-1-one
    参考文献:
    名称:
    查耳酮作为H1N1神经氨酸酶抑制剂的设计,合成和评估
    摘要:
    基于异寡糖原蛋白(最活跃的天然查尔酮非竞争性神经氨酸酶(NA)抑制剂)设计了一系列查尔酮衍生物(1a – 2i)。分子模型研究表明,异寡糖原蛋白及其设计的类似物占据了NA的430环腔,并与催化位点残基相互作用。合成了有利的衍生物,并评价了其对H1N1病毒的细胞毒性和对细胞病变作用的抑制作用。通过血凝(HA)测定,H1N1-NA抑制和抑制动力学进一步量化了抑制作用。HA分析表明,化合物1e的最低EC 50为1.71 nM。相反,H1N1-NA抑制试验显示化合物1f具有3.58μM的IC 50最佳活性。酶动力学研究表明化合物1f和2f的抑制机理是非竞争性的。
    DOI:
    10.1007/s00044-017-2124-2
点击查看最新优质反应信息

文献信息

  • Synthesis and Fungicidal Evaluation of Novel Chalcone-Based Strobilurin Analogues
    作者:Pei-Liang Zhao、Chang-Ling Liu、Wei Huang、Ya-Zhou Wang、Guang-Fu Yang
    DOI:10.1021/jf071064x
    日期:2007.7.1
    good in vivo fungicidal activities against Pseudoperoniospora cubensis and Sphaerotheca fuliginea at the dosage of 200 microg mL(-1). Two compounds, (E)-methyl 2-[2-(3-[(E)-3-(2-chlorophenyl)acryloyl]phenoxy}methyl)phenyl]-3-methoxyacrylate (1e) and (E)-methyl 2-[2-(3-[(E)-3-(3-bromophenyl)acryloyl]phenoxy}methyl)phenyl]-3-methoxyacrylate (1l), were found to display higher fungicidal activities against
    由于新的作用方式,广泛的杀真菌谱,对哺乳动物细胞的较低毒性以及环境友好的特性,Strobilururin衍生物已成为最重要的农业杀菌剂类别之一。为了发现对抵抗病原体具有高活性的新strobilurin类似物,通过将查尔酮支架与strobilurin药效团整合在一起,设计并合成了一系列基于查尔酮的新strobilurin衍生物。初步的生物测定表明,某些查尔酮类似物在200微克mL(-1)的剂量下对立方假单胞菌孢子和短小球菌具有良好的体内杀真菌活性。两种化合物 (E)-甲基2- [2-(3-[(E)-3-(2-氯苯基)丙烯酰基]苯氧基}甲基)苯基] -3-甲氧基丙烯酸酯(1e)和(E)-甲基2- [发现2-(3-[(E)-3-(3-溴苯基)丙烯酰基]苯氧基}甲基)苯基] -3-甲氧基丙烯酸酯(1l)显示出更高的杀真菌活性(EC90 = 118.52 microg相对于Kresoxim-methyl(EC90
  • [EN] INDENONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME<br/>[FR] DÉRIVÉ D'INDÉNONE ET COMPOSITION PHARMACEUTIQUE LE COMPRENANT
    申请人:KOREA RES INST CHEM TECH
    公开号:WO2011030955A1
    公开(公告)日:2011-03-17
    An indenone derivative of formula (1) is effective in enhancing the activity of osteoblastic cells and inhibiting bone resorption by osteoclastic cells, and a pharmaceutical composition comprising the indenone derivative or a pharmaceutically acceptable salt thereof is useful for preventing or treating bone diseases such as osteoporosis.
    式(1)的吲哚酮衍生物能够增强成骨细胞的活性,抑制破骨细胞的骨吸收作用,含有该吲哚酮衍生物或其药用盐的药用组合物可用于预防或治疗骨质疏松等骨病。
  • Indenone Derivative and Pharmaceutical Composition Comprising Same
    申请人:Heo Jung Nyoung
    公开号:US20120214991A1
    公开(公告)日:2012-08-23
    An indenone derivative of formula (1) is effective in enhancing the activity of osteoblastic cells and inhibiting bone resorption by osteoclastic cells, and a pharmaceutical composition comprising the indenone derivative or a pharmaceutically acceptable salt thereof is useful for preventing or treating bone diseases such as osteoporosis.
    式(1)的吲哚酮衍生物能够有效增强成骨细胞的活性,抑制破骨细胞的骨吸收作用,含有该吲哚酮衍生物或其药学上可接受的盐的药物组合物对预防或治疗骨疾病如骨质疏松症具有益处。
  • Design, synthesis and evaluation of chalcones as H1N1 Neuraminidase inhibitors
    作者:Anand S. Chintakrindi、Devanshi J. Gohil、Sweta T. Kothari、Abhay S. Chowdhary、Meena A. Kanyalkar
    DOI:10.1007/s00044-017-2124-2
    日期:2018.4
    A series of chalcone derivatives (1a–2i) were designed based on isoliquiritigenin (the most active natural chalcone non-competitive neuraminidase (NA) inhibitor). Molecular modeling studies revealed that isoliquiritigenin and its designed analogs occupied 430-loop cavity of NA and interacted favorably with catalytic site residues. The favorable derivatives were synthesized and evaluated for cytotoxicity
    基于异寡糖原蛋白(最活跃的天然查尔酮非竞争性神经氨酸酶(NA)抑制剂)设计了一系列查尔酮衍生物(1a – 2i)。分子模型研究表明,异寡糖原蛋白及其设计的类似物占据了NA的430环腔,并与催化位点残基相互作用。合成了有利的衍生物,并评价了其对H1N1病毒的细胞毒性和对细胞病变作用的抑制作用。通过血凝(HA)测定,H1N1-NA抑制和抑制动力学进一步量化了抑制作用。HA分析表明,化合物1e的最低EC 50为1.71 nM。相反,H1N1-NA抑制试验显示化合物1f具有3.58μM的IC 50最佳活性。酶动力学研究表明化合物1f和2f的抑制机理是非竞争性的。
  • Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines
    作者:Farzana Latif Ansari、Fatima Iftikhar、Ihsan-ul-Haq、Bushra Mirza、Mohammad Baseer、Umer Rashid
    DOI:10.1016/j.bmc.2008.07.009
    日期:2008.8
    Solid-phase synthesis of a parallel library of 3'-hydroxy-2,3-dihydrobenzothiazepines has been carried out through [4+3] annulation of alpha,beta-unsaturated ketones with aminothiophenol, using Wang resin as solid support. The synthesized compounds were evaluated for their potential as antibacterial, tumor inhibitors as well as acetyl- and butyrylcholinesterase inhibitors. None of the compounds showed any significant antibacterial activity. However, quite a few compounds showed significant potential as crown gall tumor inhibitors. These results reflect a strong exploratory potential in search of new benzothiazepines as source of anticancer agents. The results of the inhibition of cholinesterase revealed that benzothiazepines have a greater potential as butyrylcholinesterase inhibitors as compared to acetylcholinesterase. Moreover, the substitution of hydroxy group at C-3 in ring A led to increased activity when compared to unsubstituted- and 2'-OH substituted benzothiazepines. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多